Yet, under federal law, it is labeled "rare" because that definition is based on prevalence —a static snapshot of how many ...

Amyotrophic Lateral Sclerosis (ALS), or Lou Gehrig's disease, can affect the way you move, breathe, eat, and behave.

In ALS, the loss of certain proteins turns off a gene called UNC13A that needs to stay active for nerve cell communication, a ...

Neuvivo and the FDA have agreed on a regulatory pathway for NP001 (sodium chlorite) to treat ALS, with Phase 3 testing ...

Study shows how ALS-linked mutations disrupt the protein TDP-43 at the atomic level, preventing it from executing its ...

Neuralink is crossing the pond. Elon Musk’s brain chip is due to start clinical trials in Great Britain, and he is inviting ...

Amyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disease characterized by the progressive degeneration of motor neurons, leading to muscle weakness and eventually death.

Neuralink launched the first European clinical trial in the UK to test brain implants that let paralyzed patients control ...

The FDA has missed the date for Coya Therapeutics’ investigational new drug (IND) application, citing a lack of resources and ...

The Boxing Event brings fighters from across Texas to the ring — all to raise money for gym, nonprofits and raise awareness ...